Janux Therapeutics Inc (NASDAQ: JANX) established initial surge of 4.02% at $13.98, as the Stock market unbolted on Wednesday, before settling in for the price of $13.44 at the close. Taking a more long-term approach, JANX posted a 52-week range of $13.26-$61.59.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -67.90%. Meanwhile, its Annual Earning per share during the time was -67.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -54.26%. This publicly-traded company’s shares outstanding now amounts to $60.12 million, simultaneously with a float of $53.81 million. The organization now has a market capitalization sitting at $840.87 million. At the time of writing, stock’s 50-day Moving Average stood at $22.07, while the 200-day Moving Average is $24.65.
Janux Therapeutics Inc (JANX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Janux Therapeutics Inc industry. Janux Therapeutics Inc’s current insider ownership accounts for 10.54%, in contrast to 106.93% institutional ownership. According to the most recent insider trade that took place on Jan 02 ’26, this organization’s Chief Business Officer sold 1,879 shares at the rate of 13.73, making the entire transaction reach 25,799 in total value, affecting insider ownership by 83,095. Preceding that transaction, on Jan 02 ’26, Company’s Chief Scientific Officer sold 2,505 for 13.73, making the whole transaction’s value amount to 34,394. This particular insider is now the holder of 124,425 in total.
Janux Therapeutics Inc (NASDAQ: JANX) Trading Performance Indicators
Let’s observe the current performance indicators for Janux Therapeutics Inc (JANX). It’s Quick Ratio in the last reported quarter now stands at 35.86. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 84.09.
In the same vein, JANX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.68, a figure that is expected to reach -0.62 in the next quarter, and analysts are predicting that it will be -2.83 at the market close of one year from today.
Technical Analysis of Janux Therapeutics Inc (JANX)
Now, what If we examine the latest scores posted by [Janux Therapeutics Inc, JANX]. During the last 5-days, its volume was lower the volume of 1.89 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 37.34% While, its Average True Range was 33.86.
Raw Stochastic average of Janux Therapeutics Inc (JANX) in the period of the previous 100 days is set at 3.26%, which indicates a major fall in contrast to 41.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.50 that was lower than 1.35 volatility it exhibited in the past 100-days period.
